In addition, people with CD36 deficiency develop postprandial hypertriglyceridemia, IR, and cardiovascular disease through enhanced lipoprotein remnant levels in plasma (Masuda et al., 2009). This evidence concerns the gene CD36 and cardiovascular disorder.